Reblozyl 59572-0775
Generic: Luspatercept
Product NDC
59572-0775- Manufacturer
- Celgene Corporation
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 8, 2019
- Listing Expires
- December 31, 2027
- Application
- BLA761136
Need to source Reblozyl? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Luspatercept | 75 mg/1 |
Drug Class
Erythroid Maturation Agent [EPC]Erythroid Maturation Agent [EPC]Increased Erythroid Cell Production [PE]
Packaging Options(1)
1 VIAL, GLASS in 1 CARTON (59572-775-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS